William Febbo | executive |
Edward Stelmakh | executive |
Thomas Kelliher | analyst |
Stephen Silvestro | executive |
Jared Haase | analyst |
David Grossman | analyst |
Neil Chatterji | analyst |
Andrew D'Silva | executive |
Eric Martinuzzi | analyst |
Richard Baldry | analyst |
Good morning, everyone, and thank you for joining OptimizeRx Third Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Chief Financial Officer, Ed Stelmakh; President, Steve Silvestro; General Counsel, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.
At the conclusion of today's earnings call, I will provide some important cautions regarding the forward-looking statements made by the management during today's call.